Related Experiment Video
Updated: Sep 23, 2025

Author Spotlight: Advancing Real-Time cAMP Detection in Cells Using cADDis Biosensor
Published on: March 22, 2024
Adenylate cyclase type 9 antagonizes cAMP accumulation and regulates endothelial signalling involved in
Yohann Rautureau1, Marianne Berlatie1, Daniel Rivas1
1Montreal Heart Institute, Université de Montréal, Montreal, Canada.
Insights
Adenylate cyclase type 9 (ADCY9) regulates endothelial cell function and permeability, impacting atherosclerosis development. Its inactivation improves endothelial function and reduces atherosclerotic lesion progression in mice.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Endothelial Cell Biology
Background:
- The adenylate cyclase type 9 (ADCY9) gene is implicated in atherosclerotic outcomes.
- Previous studies in mice showed Adcy9 inactivation improves endothelial function and inhibits atherogenesis.
Purpose of the Study:
- To investigate the role of ADCY9 in regulating endothelial signaling pathways relevant to atherosclerosis.
Main Methods:
- Examined ADCY9 expression in mouse arteries.
- Investigated the effects of ADCY9 manipulation on cAMP levels and endothelial cell function in vitro.
- Assessed vasodilation, endothelial permeability, and VASP phosphorylation in response to various stimuli in mouse models and human cells.
Main Results:
- ADCY9 is expressed in the endothelium and its inactivation enhances cAMP accumulation and potentiates vasodilation.
- Adcy9 inactivation reduces endothelial permeability and inhibits atherogenesis.
- ADCY9 manipulation affects VASP phosphorylation and RAP1 activity, influencing endothelial barrier function.
Conclusions:
- ADCY9 is expressed in endothelial cells and plays a critical role in regulating local cAMP levels.
- ADCY9 influences endothelial functions, including permeability, which are relevant to the pathogenesis of atherosclerosis.
Aims:
The adenylate cyclase type 9 (ADCY9) gene appears to determine atherosclerotic outcomes in patients treated with dalcetrapib. In mice, we recently demonstrated that Adcy9 inactivation potentiates endothelial function and inhibits atherogenesis. The objective of this study was to characterize the contribution of ADCY9 to the regulation of endothelial signalling pathways involved in atherosclerosis.
Methods And Results:
We show that ADCY9 is expressed in the endothelium of mouse aorta and femoral arteries. We demonstrate that ADCY9 inactivation in cultured endothelial cells paradoxically increases cAMP accumulation in response to the adenylate cyclase activators forskolin and vasoactive intestinal peptide (VIP). Reciprocally, ADCY9 overexpression decreases cAMP production. Using mouse femoral artery arteriography, we show that Adcy9 inactivation potentiates VIP-induced endothelial-dependent vasodilation. Moreover, Adcy9 inactivation reduces mouse atheroma endothelial permeability in different vascular beds. ADCY9 overexpression reduces forskolin-induced phosphorylation of Ser157-vasodilator-stimulated phosphoprotein (VASP) and worsens thrombin-induced fall of RAP1 activity, both leading to increased endothelial permeability. ADCY9 inactivation in thrombin-stimulated human coronary artery endothelial cells results in cAMP accumulation, increases p-Ser157-VASP, and inhibits endothelial permeability. MLC2 phosphorylation and actin stress fibre increases in response to thrombin were reduced by ADCY9 inactivation, suggesting actin cytoskeleton regulation. Finally, using the Miles assay, we demonstrate that Adcy9 regulates thrombin-induced endothelial permeability in vivo in normal and atherosclerotic animals.
Conclusion:
Adcy9 is expressed in endothelial cells and regulates local cAMP and endothelial functions including permeability relevant to atherogenesis.
More Related Videos
09:39Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
08:49Mapping the Cellular Distribution of an Optogenetic Protein Using a Light-Stimulation Grid
Published on: January 26, 2024
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
GPCRs Regulate Adenylyl Cylase Activity
Nitric Oxide Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Intracellular Signaling Cascades
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...